☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - January 2023

January 17, 2023 at 9:58 am | In Prescribing Extra - Drugs | Print Print | No Comments

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Estetrol / drospirenone (Drovelis®) has been rejected for use as an oral contraceptive. The manufacture failed to make a submission for this indication.

Ferric maltol (Feraccru®) has been rejected for use in adults for the treatment of iron deficiency. The submitting company did not present a sufficiently robust clinical and economic analysis to gain acceptance by SMC.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - January 2023' by emailShare 'SMC Update - January 2023' on FacebookShare 'SMC Update - January 2023' on TwitterShare 'SMC Update - January 2023' on MastodonShare 'SMC Update - January 2023' on LinkedInShare 'SMC Update - January 2023' on reddit

Copyright © 2023 Prescribing Advice for GPs

No Comments to “SMC Update - January 2023”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.